Publisher
Springer Science and Business Media LLC
Reference7 articles.
1. Cooperberg MR, Broering JM, Kantoff PW, Carroll PR (2007) Cooperberg MR, et al Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol 178(3 Pt 2):S14–S19
2. Welch HG, Black WC (2010) Overdiagnosis in cancer. Natl Cancer Inst 102(9):605–613
3. Laurence K (2002) Expectant management with selective delayed intervention for favorable risk prostate cancer. Urol Oncol 7:175–179
4. Ioannidis J (2020) Infection fatality rate of COVID-19 inferred from seroprevalence data. Publication of the WHO Article ID: BLT.20.265892
5. Klotz L, Vesprini D, Sethukavalan P, Jethava V, Zhang L, Jain S, Yamamoto T, Mamedov A (2015) Loblaw Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol 33(3):272–277
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献